Patents by Inventor David Lee Thomas

David Lee Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11180758
    Abstract: Three proteins, BCL-G (BCL2L14), CMPK2, and LAMP3, were discovered to independently restrict HIV-1 replication both in-vivo and in-vitro. Methods are described wherein subjects are given an effective amount of a pharmaceutical composition comprising a protein selected from the group consisting of BCL-G, CMPK2, LAMP3, functional parts thereof, recombinant proteins thereof, and combinations thereof, for the purpose of treating or preventing HIV.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: November 23, 2021
    Assignee: The Johns Hopkins University
    Inventors: David Lee Thomas, Ashwin Balagopal, Ramy El-Diwany, Robert Siliciano, Joel Blankson, Stuart C Ray, Michel Anand Chattergoon, Justin Bailey
  • Publication number: 20190085333
    Abstract: Three proteins, BCL-G (BCL2L14), CMPK2, and LAMP3, were discovered to independently restrict HIV-1 replication both in-vivo and in-vitro. Methods are described wherein subjects are given an effective amount of a pharmaceutical composition comprising a protein selected from the group consisting of BCL-G, CMPK2, LAMP3, functional parts thereof, recombinant proteins thereof, and combinations thereof, for the purpose of treating or preventing HIV.
    Type: Application
    Filed: February 24, 2017
    Publication date: March 21, 2019
    Inventors: David Lee Thomas, Ashwin Balagopal, Ramy El-Diwany, Robert Siliciano, Joel Blankson, Stuart C Ray, Michel Anand Chattergoon, Justin Bailey
  • Patent number: D936424
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: November 23, 2021
    Inventor: David Lee Thomas, Jr.